N. Prasad
Nessuna posizione attualmente
Storia della carriera di N. Prasad
Precedenti posizioni note di N. Prasad
Società | Posizione | Inizio | Fine |
---|---|---|---|
MYLAN LABORATORIES LTD | Direttore/Membro del Consiglio | - | 21/08/2009 |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Corporate Officer/Principal | 01/01/2007 | 02/10/2007 |
Sanofi-Aventis India Ltd.
Sanofi-Aventis India Ltd. Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis India Ltd. engages in the research, production and distribution of pharmaceutical products. It provides medicines for the treatment of patients in several therapeutic areas such as cardiovascular, thrombotic diseases, metabolic disorders, oncology and disorders of the central nervous system. The company is headquartered in Mumbai, India. | Vendite & Marketing | 01/01/1989 | - |
Vorin Laboratories Ltd. | Corporate Officer/Principal | 01/01/1995 | - |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Direttore/Membro del Consiglio | 01/01/2007 | - |
Formazione di N. Prasad
University of Delhi | Graduate Degree |
Institute of Management Technology | Masters Business Admin |
Statistiche
Distribuzione geografica
India | 6 |
Stati Uniti | 3 |
Posizioni
Director/Board Member | 2 |
Corporate Officer/Principal | 2 |
Graduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 3 |
Commercial Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 5 |
---|---|
Mylan Laboratories Ltd.
Mylan Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India. | Health Technology |
Mylan Laboratories, Inc.
Mylan Laboratories, Inc. Pharmaceuticals: GenericHealth Technology Mylan Laboratories, Inc. is engaged in developing, licensing, manufacturing, marketing and distributing generic and brand pharmaceutical products. The company manufactures and markets over 140 generic products in approximately 360 product strengths covering over 40 therapeutic categories. The company manufactures products for conditions ranging from angina to arthritis, depression to diabetes, pain to Parkinson's disease and schizophrenia to sleep disorders. The company operates through its three subsidiaries: a) Mylan Pharmaceuticals (Morgantown, West Virginia) is primarily focused on solid oral dose generic pharmaceutical products. b) Mylan Technologies (St. Albans, Vermont) is the pioneer in generic transdermal drug delivery technology and is the producer of generic transdermal patches for the U.S. market. c) UDL Laboratories (Rockford, Illinois) is the number one supplier of unit dose pharmaceuticals to hospitals and other institutions across the United States. The company was incorporated in 1970 and is headquartered in Canonsburg, PA. | Health Technology |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Vorin Laboratories Ltd. | |
Sanofi-Aventis India Ltd.
Sanofi-Aventis India Ltd. Miscellaneous Commercial ServicesCommercial Services Sanofi-Aventis India Ltd. engages in the research, production and distribution of pharmaceutical products. It provides medicines for the treatment of patients in several therapeutic areas such as cardiovascular, thrombotic diseases, metabolic disorders, oncology and disorders of the central nervous system. The company is headquartered in Mumbai, India. | Commercial Services |
- Borsa valori
- Insiders
- N. Prasad
- Esperienza